Viewing Study NCT07175051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-06-21 @ 8:32 AM
Study NCT ID: NCT07175051
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2025-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Sponsor: University of Illinois at Chicago
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) View
None Albuminuria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Empa-CKD View
None Sickle Cell-Related Kidney Disease View